Global Healthcare Contract Research Organization (CRO) Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global healthcare contract research organization (CRO) market in its upcoming report titled, “Global Healthcare Contract Research Organization (CRO) Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2027”. The global healthcare contract research organization (CRO) market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global healthcare contract research organization (CRO) market report has been segmented on the basis of type, service, and region.

Request Covid - 19 Impact

This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.

A contract research organization (CRO) is a company provides support to pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on the basis of contract.

Rising development cost of the drugs is a key factor expected to drive growth of the global market over the forecast period. In addition, increasing incidence of chronic diseases such as cancer, Alzheimer’s, diabetes, and many infectious diseases in children, and rising government funding are other factors expected to further fuel growth of the target market. Furthermore, growing research and development activities and increasing preference towards outsourcing activities, owing to it time and cost effectiveness are other factors expected to boost growth of this market in the near future.

However, stringent government regulation for approval of pharmaceutical and biopharmaceutical products or drugs is a key factor expected to restrain growth of the global market over the forecast period. In addition, lack of skilled research experts is another factor expected to hamper growth of the target market in the near future.

Increasing technological advancements, rising demand for innovative products, and rising investment in research and development activities across the globe are expected to create potential revenue opportunities for players operating in the target market in the near future.

The market in North America dominates the global market in terms of revenue, owing to rapidly growing industries, increasing government initiatives for research and development activities, and developed healthcare infrastructure in various countries in the region. The market in Europe is expected to account for second-highest share in terms of revenue over the forecast period, owing to availability of government funding for various healthcare projects in various countries in the region. The market in Asia Pacific is expected to register significant share in terms of revenue over the forecast period, owing to increasing incidence of chronic and lifestyle diseases such as diabetes and heart attack, increasing patient’s requirements, and availability of advanced technologies in various developing countries in the region.

Global healthcare contract research organization (CRO) market segmentation:

Segmentation by type:

• Drug Discovery
  • Target validation
  • Lead identification
  • Lead optimization
• Pre-Clinical
• Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

Segmentation by service:

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient and site Recruitment
• Technology

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Quintiles, Inc.
• Covance Inc.
• Pharmaceutical Product Development, LLC Company
• PAREXEL International Corporation
• Charles River Laboratories, Inc.
• ICON Public Limited Company
• inVentiv Health, Inc.
• Medidata Solutions, Inc.
• Theorem Clinical Research Inc.
• Syneos Health, Inc.